Log in to save to my catalogue

L-type Ca 2+ channel blockers promote vascular remodeling through activation of STIM proteins

L-type Ca 2+ channel blockers promote vascular remodeling through activation of STIM proteins

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_2007598117

L-type Ca 2+ channel blockers promote vascular remodeling through activation of STIM proteins

About this item

Full title

L-type Ca 2+ channel blockers promote vascular remodeling through activation of STIM proteins

Publisher

United States

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2020-07, Vol.117 (29), p.17369-17380

Language

English

Formats

Publication information

Publisher

United States

More information

Scope and Contents

Contents

Voltage-gated L-type Ca
channel (Ca
1.2) blockers (LCCBs) are major drugs for treating hypertension, the preeminent risk factor for heart failure. Vascular smooth muscle cell (VSMC) remodeling is a pathological hallmark of chronic hypertension. VSMC remodeling is characterized by molecular rewiring of the cellular Ca
signaling machinery, i...

Alternative Titles

Full title

L-type Ca 2+ channel blockers promote vascular remodeling through activation of STIM proteins

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1073_pnas_2007598117

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_2007598117

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.2007598117

How to access this item